Security
Avalo Therapeutics Inc. · COM NEW
9 owners 1 new max 0.1% (Farallon Capital Manageme...)
owners
9
max %
0.1%
tracked value
$75M
qoq
N 1
A 5
R 2
holders
sorted by % of portfolio · long equity only
| manager | % port | activity | shares | value | history |
|---|---|---|---|---|---|
| Farallon Capital Management LLC 2026 Q1 | 0.1% | New 0.1% | 916,000 | $14M | hist |
| Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 | 0.0% | Add 0.00 pp | 916,142 | $14M | hist |
| Israel Englander - Millennium Management LLC 2026 Q1 | 0.0% | Add 0.00 pp | 835,484 | $12M | hist |
| Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 | 0.0% | Add 0.00 pp | 731,586 | $11M | hist |
| Vanguard Group Inc. 2025 Q4 stale | 0.0% | Add 0.00 pp | 804,084 | $15M | hist |
| Ken Griffin - Citadel Advisors LLC 2026 Q1 | 0.0% | Reduce 0.00 pp | 193,735 | $3M | hist |
| Two Sigma Investments, LP 2025 Q4 stale | 0.0% | Exit 0.00 pp | 148,237 | $3M | hist |
| Marshall Wace - Marshall Wace, LLP 2026 Q1 | 0.0% | Reduce -0.01 pp | 129,136 | $2M | hist |
| Renaissance Technologies LLC 2026 Q1 | 0.0% | Add 0.00 pp | 120,114 | $2M | hist |
No managers match this filter.
financials
US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing
Income statement
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $8.4M | $138.89M | $105.29M |
| Total non-current assets * | $12.6M | $11.84M | $11.17M |
| Total assets | $20.99M | $150.73M | $116.46M |
| Total current liabilities | $4.62M | $6.96M | $12.94M |
| Total non-current liabilities * | $9.07M | $10.74M | $20.47M |
| Total equity | $7.3M | $133.03M | $83.05M |
ownership over time
filing count by report period · click a bar for that quarter’s holders